Contemporary OB/GYN week in review: maternal vaccination, intrapartum fever, and more

News
Article

Review some of the top stories from the Contemporary OB/GYN website over the last week, and catch up on anything you may have missed.

Contemporary OB/GYN week in review: maternal vaccination, intrapartum fever, and more

Contemporary OB/GYN week in review: maternal vaccination, intrapartum fever, and more

Thank you for visiting the Contemporary OB/GYN® website. Take a look at some of our top stories from last week (Monday, November 13 - Friday, November 17, 2023), and click each link to read and watch anything you may have missed.

1.) The importance of maternal vaccination

Robert H. Hopkins, Jr, MD, discusses the importance of pregnant women receiving vaccines against respiratory diseases to protect themselves and their infants.

Click here for the full article.

2.) Managing intrapartum fever: Ampicillin vs ampicillin and gentamicin

Discover key findings from a recent study suggesting increased risks with ampicillin treatment for intrapartum fever, emphasizing the importance of considering ampicillin and gentamicin for comprehensive management of clinical chorioamnionitis during childbirth.

Click here for the full article.

3.) Recurrent severe maternal morbidity: Risks in subsequent pregnancies

Dig into the latest research exposing the hidden dangers of recurrent severe maternal morbidity in subsequent pregnancies.

Click here for the full article.

4.) Smart Women’s Choice faces federal court order to halt unlawful contraceptive distribution

The US District Court for the District of Arizona issued an order against Arizona-based company Smart Women’s Choice, Inc, following a complaint by the US Department of Justice, alleging the distribution of unapproved new drugs in violation of the Federal Food, Drug, and Cosmetic Act.

Click here for the full article.

5.) Catch-up HPV test offers high predictability for cervical cancer risk in older women

A recent study suggests that a catch-up HPV test may significantly enhance cervical cancer prediction for women aged 65 and older, potentially addressing issues in existing screening programs and reducing the risk of cervical cancer development.

Click here for the full article.

Related Videos
Understanding combined oral contraceptives and breast cancer risk | Image Credit: health.ucdavis.edu
The importance of nipocalimab’s FTD against FNAIT | Image Credit:  linkedin.com
Enhancing cervical cancer management with dual stain | Image Credit: linkedin.com
Fertility treatment challenges for Muslim women during fasting holidays | Image Credit: rmanetwork.com
CDC estimates of maternal mortality found overestimated | Image Credit: rwjms.rutgers.edu.
Study unveils maternal mortality tracking trends | Image Credit: obhg.com
How Harmonia Healthcare is revolutionizing hyperemesis gravidarum care | Image Credit: hyperemesis.org
Exploring the intersection of heart health and women's health | Image Credit: cedars-sinai.org
Unlocking the benefits of DHEA | Image Credit: drannacabeca.com
Related Content
© 2024 MJH Life Sciences

All rights reserved.